We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Real-Time Mobile Laboratory Developed for Needle Device

By LabMedica International staff writers
Posted on 12 Oct 2015
Print article
Image: The two key lab in a chip components with a syringe for scale, which will allow for rapid liver toxicity tests (Photo courtesy of Nanyang Technological University).
Image: The two key lab in a chip components with a syringe for scale, which will allow for rapid liver toxicity tests (Photo courtesy of Nanyang Technological University).
A truly practical lab-on-a-chip (LOC) system for point-of-care testing (POCT) hepatotoxicity assessment necessitates the embodiment of full-automation, ease-of-use and “sample-in-answer-out” diagnostic capabilities.

A laboratory in a needle device has been developed that could provide instant results to routine laboratory tests, accelerating treatment and diagnosis by days. This single, self-contained medical device will be effective, for example, in quickly detecting liver toxicity which is a common side effect of chemotherapy. This device will test toxicity in 30 minutes while current liver toxicity tests take several days due to multiple steps required before a physician interprets the test results and communicates them to the patient.

Scientists at Houston Methodist Research Institute (TX, USA) working with colleagues in Singapore developed an integrated LOC system that is somewhat close to a practical POCT hepatotoxicity assessment device as it embodies both tissue sample preparation and multiplex real-time reverse transcriptase polymerase chain reaction (RT-PCR). It features semi-automation, is relatively easy to use, and has “sample-in-answer-out” capabilities for multiplex gene expression analysis.

The tissue sample preparation module incorporated both a micro-homogenizer and surface-treated paramagnetic microbeads that yielded high-purity messenger ribonucleic (mRNA) extracts— considerably better than manual means of extraction. A primer preloading surface treatment procedure and the single-loading inlet on the multiplex real-time RT-PCR module simplified off-chip handling procedures for ease-of-use. Elevations in the two examined gene markers of liver toxicity were then accurately detected and consistent with previously known changes, indicating that lab in a needle is an appropriate diagnostic option.

Joseph S. Chang, PhD, a professor at Nanyang Technological University (Singapore) and a senior author of the study said, “What we have proven is when the doctor takes a blood or liver sample, the sample can be prepared and analyzed using lab on a chip methods which eliminates the need for wet laboratory work and experts. Our method significantly reduces time, manpower and costs and yet has the same accurate results.” The study was published on September 2, 2105 in the journal Lab on a Chip.

Related Links:

Houston Methodist Research Institute
Nanyang Technological University 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.